ASTRAZENECA PLC (ZEG.DE) Stock Fundamental Analysis
Europe - FRA:ZEG - GB0009895292 - Common Stock
143.4 EUR
0 (0%)
Taking everything into account, ZEG scores 5 out of 10 in our fundamental rating. ZEG was compared to 52 industry peers in the Pharmaceuticals industry. ZEG scores excellent on profitability, but there are concerns on its financial health. ZEG is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
ZEG had positive earnings in the past year.
In the past year ZEG had a positive cash flow from operations.
In the past 5 years ZEG has always been profitable.
ZEG had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
ZEG has a Return On Assets (7.38%) which is in line with its industry peers.
The Return On Equity of ZEG (18.55%) is better than 61.54% of its industry peers.
ZEG has a better Return On Invested Capital (14.26%) than 73.08% of its industry peers.
ZEG had an Average Return On Invested Capital over the past 3 years of 11.62%. This is below the industry average of 15.23%.
The last Return On Invested Capital (14.26%) for ZEG is above the 3 year average (11.62%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.38% | ||
| ROE | 18.55% | ||
| ROIC | 14.26% |
ROA(3y)5.35%
ROA(5y)4.19%
ROE(3y)13.78%
ROE(5y)12.42%
ROIC(3y)11.62%
ROIC(5y)9.52%
1.3 Margins
ZEG has a Profit Margin (14.68%) which is in line with its industry peers.
In the last couple of years the Profit Margin of ZEG has grown nicely.
With a decent Operating Margin value of 24.39%, ZEG is doing good in the industry, outperforming 61.54% of the companies in the same industry.
In the last couple of years the Operating Margin of ZEG has grown nicely.
ZEG has a Gross Margin of 82.07%. This is amongst the best in the industry. ZEG outperforms 82.69% of its industry peers.
In the last couple of years the Gross Margin of ZEG has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 24.39% | ||
| PM (TTM) | 14.68% | ||
| GM | 82.07% |
OM growth 3Y21.43%
OM growth 5Y8.6%
PM growth 3Y251.6%
PM growth 5Y18.9%
GM growth 3Y3.31%
GM growth 5Y0.47%
2. Health
2.1 Basic Checks
ZEG has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
ZEG has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for ZEG has been increased compared to 5 years ago.
Compared to 1 year ago, ZEG has a worse debt to assets ratio.
2.2 Solvency
ZEG has an Altman-Z score of 5.55. This indicates that ZEG is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 5.55, ZEG is in the better half of the industry, outperforming 76.92% of the companies in the same industry.
The Debt to FCF ratio of ZEG is 4.01, which is a neutral value as it means it would take ZEG, 4.01 years of fcf income to pay off all of its debts.
ZEG has a Debt to FCF ratio (4.01) which is in line with its industry peers.
A Debt/Equity ratio of 0.63 indicates that ZEG is somewhat dependend on debt financing.
ZEG has a Debt to Equity ratio of 0.63. This is comparable to the rest of the industry: ZEG outperforms 50.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.63 | ||
| Debt/FCF | 4.01 | ||
| Altman-Z | 5.55 |
ROIC/WACC1.59
WACC8.98%
2.3 Liquidity
ZEG has a Current Ratio of 0.86. This is a bad value and indicates that ZEG is not financially healthy enough and could expect problems in meeting its short term obligations.
ZEG has a Current ratio of 0.86. This is in the lower half of the industry: ZEG underperforms 78.85% of its industry peers.
ZEG has a Quick Ratio of 0.86. This is a bad value and indicates that ZEG is not financially healthy enough and could expect problems in meeting its short term obligations.
ZEG has a Quick ratio of 0.67. This is in the lower half of the industry: ZEG underperforms 76.92% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.86 | ||
| Quick Ratio | 0.67 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 22.30% over the past year.
Measured over the past years, ZEG shows a quite strong growth in Earnings Per Share. The EPS has been growing by 18.59% on average per year.
The Revenue has grown by 15.00% in the past year. This is quite good.
The Revenue has been growing by 17.27% on average over the past years. This is quite good.
EPS 1Y (TTM)22.3%
EPS 3Y15.85%
EPS 5Y18.59%
EPS Q2Q%9.6%
Revenue 1Y (TTM)15%
Revenue growth 3Y13.06%
Revenue growth 5Y17.27%
Sales Q2Q%11.74%
3.2 Future
ZEG is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.44% yearly.
ZEG is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.04% yearly.
EPS Next Y13.74%
EPS Next 2Y13.62%
EPS Next 3Y12.75%
EPS Next 5Y12.44%
Revenue Next Year9.63%
Revenue Next 2Y7.79%
Revenue Next 3Y7.1%
Revenue Next 5Y7.04%
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 18.87, which indicates a rather expensive current valuation of ZEG.
The rest of the industry has a similar Price/Earnings ratio as ZEG.
Compared to an average S&P500 Price/Earnings ratio of 26.89, ZEG is valued a bit cheaper.
Based on the Price/Forward Earnings ratio of 15.71, the valuation of ZEG can be described as correct.
ZEG's Price/Forward Earnings is on the same level as the industry average.
ZEG is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.99, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.87 | ||
| Fwd PE | 15.71 |
4.2 Price Multiples
ZEG's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. ZEG is more expensive than 65.38% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ZEG is valued a bit more expensive than the industry average as 63.46% of the companies are valued more cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 63.08 | ||
| EV/EBITDA | 26.2 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
ZEG has a very decent profitability rating, which may justify a higher PE ratio.
ZEG's earnings are expected to grow with 12.75% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.37
PEG (5Y)1.01
EPS Next 2Y13.62%
EPS Next 3Y12.75%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 1.96%, ZEG has a reasonable but not impressive dividend return.
ZEG's Dividend Yield is comparable with the industry average which is at 2.98.
ZEG's Dividend Yield is comparable with the S&P500 average which is at 2.31.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.96% |
5.2 History
The dividend of ZEG has a limited annual growth rate of 1.40%.
Dividend Growth(5Y)1.4%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
59.51% of the earnings are spent on dividend by ZEG. This is a bit on the high side, but may be sustainable.
ZEG's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP59.51%
EPS Next 2Y13.62%
EPS Next 3Y12.75%
FRA:ZEG (10/24/2025, 7:00:00 PM)
143.4
0 (0%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners48.98%
Inst Owner ChangeN/A
Ins Owners0.04%
Ins Owner ChangeN/A
Market Cap444.61B
Revenue(TTM)56.50B
Net Income(TTM)8.29B
Analysts81.82
Price Target154.88 (8.01%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.96% |
Yearly Dividend2.57
Dividend Growth(5Y)1.4%
DP59.51%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.79%
Min EPS beat(2)-1.74%
Max EPS beat(2)9.32%
EPS beat(4)2
Avg EPS beat(4)1.9%
Min EPS beat(4)-1.74%
Max EPS beat(4)9.32%
EPS beat(8)4
Avg EPS beat(8)1.17%
EPS beat(12)8
Avg EPS beat(12)2.95%
EPS beat(16)11
Avg EPS beat(16)2.52%
Revenue beat(2)0
Avg Revenue beat(2)-2.11%
Min Revenue beat(2)-3.99%
Max Revenue beat(2)-0.24%
Revenue beat(4)2
Avg Revenue beat(4)-0.14%
Min Revenue beat(4)-3.99%
Max Revenue beat(4)2.7%
Revenue beat(8)3
Avg Revenue beat(8)-0.29%
Revenue beat(12)4
Avg Revenue beat(12)-0.55%
Revenue beat(16)7
Avg Revenue beat(16)0.32%
PT rev (1m)-1.13%
PT rev (3m)-1.09%
EPS NQ rev (1m)0.38%
EPS NQ rev (3m)3.34%
EPS NY rev (1m)0%
EPS NY rev (3m)1.12%
Revenue NQ rev (1m)-0.11%
Revenue NQ rev (3m)0.89%
Revenue NY rev (1m)-0.05%
Revenue NY rev (3m)1.15%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.87 | ||
| Fwd PE | 15.71 | ||
| P/S | 9.14 | ||
| P/FCF | 63.08 | ||
| P/OCF | 38.56 | ||
| P/B | 11.55 | ||
| P/tB | N/A | ||
| EV/EBITDA | 26.2 |
EPS(TTM)7.6
EY5.3%
EPS(NY)9.13
Fwd EY6.37%
FCF(TTM)2.27
FCFY1.59%
OCF(TTM)3.72
OCFY2.59%
SpS15.69
BVpS12.42
TBVpS-4.01
PEG (NY)1.37
PEG (5Y)1.01
Graham Number46.09
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.38% | ||
| ROE | 18.55% | ||
| ROCE | 17.47% | ||
| ROIC | 14.26% | ||
| ROICexc | 15.63% | ||
| ROICexgc | 78.69% | ||
| OM | 24.39% | ||
| PM (TTM) | 14.68% | ||
| GM | 82.07% | ||
| FCFM | 14.48% |
ROA(3y)5.35%
ROA(5y)4.19%
ROE(3y)13.78%
ROE(5y)12.42%
ROIC(3y)11.62%
ROIC(5y)9.52%
ROICexc(3y)12.66%
ROICexc(5y)10.55%
ROICexgc(3y)112.76%
ROICexgc(5y)85.06%
ROCE(3y)13.95%
ROCE(5y)11.45%
ROICexgc growth 3Y43.28%
ROICexgc growth 5Y4.77%
ROICexc growth 3Y41%
ROICexc growth 5Y11.99%
OM growth 3Y21.43%
OM growth 5Y8.6%
PM growth 3Y251.6%
PM growth 5Y18.9%
GM growth 3Y3.31%
GM growth 5Y0.47%
F-Score7
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.63 | ||
| Debt/FCF | 4.01 | ||
| Debt/EBITDA | 1.36 | ||
| Cap/Depr | 76.24% | ||
| Cap/Sales | 9.21% | ||
| Interest Coverage | 10.19 | ||
| Cash Conversion | 64.97% | ||
| Profit Quality | 98.66% | ||
| Current Ratio | 0.86 | ||
| Quick Ratio | 0.67 | ||
| Altman-Z | 5.55 |
F-Score7
WACC8.98%
ROIC/WACC1.59
Cap/Depr(3y)61.87%
Cap/Depr(5y)60.41%
Cap/Sales(3y)7.51%
Cap/Sales(5y)7.64%
Profit Quality(3y)144.6%
Profit Quality(5y)772.45%
High Growth Momentum
Growth
EPS 1Y (TTM)22.3%
EPS 3Y15.85%
EPS 5Y18.59%
EPS Q2Q%9.6%
EPS Next Y13.74%
EPS Next 2Y13.62%
EPS Next 3Y12.75%
EPS Next 5Y12.44%
Revenue 1Y (TTM)15%
Revenue growth 3Y13.06%
Revenue growth 5Y17.27%
Sales Q2Q%11.74%
Revenue Next Year9.63%
Revenue Next 2Y7.79%
Revenue Next 3Y7.1%
Revenue Next 5Y7.04%
EBIT growth 1Y37.03%
EBIT growth 3Y37.28%
EBIT growth 5Y27.35%
EBIT Next Year34.36%
EBIT Next 3Y17.49%
EBIT Next 5Y12.9%
FCF growth 1Y24.74%
FCF growth 3Y24.58%
FCF growth 5Y70.22%
OCF growth 1Y31.54%
OCF growth 3Y25.76%
OCF growth 5Y31.92%
ASTRAZENECA PLC / ZEG.DE FAQ
What is the fundamental rating for ZEG stock?
ChartMill assigns a fundamental rating of 5 / 10 to ZEG.DE.
What is the valuation status for ZEG stock?
ChartMill assigns a valuation rating of 3 / 10 to ASTRAZENECA PLC (ZEG.DE). This can be considered as Overvalued.
What is the profitability of ZEG stock?
ASTRAZENECA PLC (ZEG.DE) has a profitability rating of 7 / 10.
Can you provide the PE and PB ratios for ZEG stock?
The Price/Earnings (PE) ratio for ASTRAZENECA PLC (ZEG.DE) is 18.87 and the Price/Book (PB) ratio is 11.55.
Can you provide the financial health for ZEG stock?
The financial health rating of ASTRAZENECA PLC (ZEG.DE) is 3 / 10.